Erin Eliabeth Nichols, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8140 Norton Pkwy Ste 110, Mentor, OH 44060 Phone: 440-255-1115 |
Carrie Happ-smith, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8140 Norton Pkwy Ste 110, Mentor, OH 44060 Phone: 440-255-1115 |
Ms. Lisa Marie Ward, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8140 Norton Pkwy Ste 110, Mentor, OH 44060 Phone: 440-255-1115 Fax: 440-255-1550 |
Dr. Gregory Clell Riffle, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8140 Norton Pkwy Ste 110, Mentor, OH 44060 Phone: 440-255-1115 Fax: 440-255-1550 |
Dr. Gregory Alan Eippert, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 8140 Norton Pkwy Ste 110, Mentor, OH 44060 Phone: 440-255-1115 Fax: 440-255-1550 |
Dr. Ronald Edgar Posner, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 9485 Mentor Ave, Ste 110, Mentor, OH 44060 Phone: 440-255-1115 |
News Archive
Kaiser Health News staff writer Chris Weaver reports on developments surrounding efforts in the Senate regarding legislation on Medicare payments to physicians. "Legislation to 'fix' Medicare's physician payment formula has stalled in the Senate, just days after Majority Leader Harry Reid, D-Nev., announced his intent to fast-track the measure.
With close to one third of the world's population infected with parasitic worms, MUHC researcher Dr. Theresa Gyorkos is thinking big when it comes to finding a solution to this global public health challenge. As part of an international research and policy team, she is contributing to the soon-to-be-released WHO Strategic Plan to control intestinal worm infections in more than 100 countries.
A loss of dietary diversity during the past 50 years could be a contributing factor to the rise in obesity, Type 2 diabetes, gastrointestinal problems and other diseases, according to a lecture by Mark Heiman, vice president and chief scientific officer at MicroBiome Therapeutics, at IFT15: Where Science Feeds Innovation hosted by the Institute of Food Technologists in Chicago.
NeoVista, Inc., announced today that the U.S. Food and Drug Administration (FDA) had approved the company's "compassionate case" waiver to utilize its novel wet age-related macular degeneration (AMD) treatment on a patient with an advanced form of the disease who did not meet criteria for inclusion into current NeoVista investigational treatment protocols.
Analyzing the genomes of twin 3-year-old sisters – one healthy and one with aggressive leukemia – led an international team of researchers to identify a novel molecular target that could become a way to treat recurring and deadly malignancies.
› Verified 4 days ago